Literature DB >> 25572164

Expression of ST3Gal, ST6Gal, ST6GalNAc and ST8Sia in human hepatic carcinoma cell lines, HepG-2 and SMMC-7721 and normal hepatic cell line, L-02.

Yan Zhang1, Wenjin Zhao, Yujie Zhao, Qun He.   

Abstract

We measured ST3Gal, ST6Gal, ST6GalNAc and ST8Sia expression in human hepatic carcinoma cell lines, HepG-2 and SMMC-7721 and normal hepatic cell line, L-02 to reveal the relationship between hepatic carcinoma cell lines sialyltransferases expression and cell membrane sialic acid sugar chains. Membrane sialic acid sugar chains in L-02, HepG-2 and SMMC-7721 cell lines were measured with lectin microarrays to find expression profiles. Expression of 20 sialyltransferases was measured with DNA microarray. qRT-PCR and Western blot were used to verify DNA microarrays data. Siaα 2-3Galβ1-3[Siaα2-6GalNAc]α-R and Siaα 2-6Gal/GalNAc sugar chains in hepatic carcinoma cell lines, HepG-2 and SMMC-7721 were upregulated, and 7differentially expressed sialyltransferases were captured. ST3Gal-IV and ST6Gal I were overexpressed and ST3Gal-I, ST3Gal-V, ST3Gal-VI, ST6GalNAcII and ST6GalNAcVI were downregulated in HepG-2 and SMMC-7721 cell Lines, compared with control cell line. ST6GalNAc-IV and ST8sia expressions were not detected. Other sialyltransferases were not different among cell lines. Results from qRT-PCR and Western blot were consistent with DNA microarray. Overexpression of ST3Gal-IV and ST6Gal I in HepG-2 and SMMC-7721 cell lines may correlate with upregulation of Siaα 2-3Galβ1-3[Siaα2-6GalNAc]α-R and Siaα 2-6Gal/GalNAc sugar chains on cell membranes.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25572164     DOI: 10.1007/s10719-014-9569-z

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  27 in total

Review 1.  Glycosyltransferases. Structure, localization, and control of cell type-specific glycosylation.

Authors:  J C Paulson; K J Colley
Journal:  J Biol Chem       Date:  1989-10-25       Impact factor: 5.157

2.  Mouse beta-galactoside alpha 2,3-sialyltransferases: comparison of in vitro substrate specificities and tissue specific expression.

Authors:  M Kono; Y Ohyama; Y C Lee; T Hamamoto; N Kojima; S Tsuji
Journal:  Glycobiology       Date:  1997-06       Impact factor: 4.313

3.  Correlation between Heterogeneous Expression of Sialyltransferases and MUC16 in Ovarian Tumor Tissues.

Authors:  Houda Bouanene; Wassila Sahrawi; Moncef Mokni; Leila Ben Fatma; Amira Bouriga; Halima Ben Limen; Hédi Khairi; Slim Ben Ahmed; Abdelhédi Miled
Journal:  Onkologie       Date:  2011-03-18

4.  Interleukin-1beta induces sialyl Lewis X on hepatocellular carcinoma HuH-7 cells via enhanced expression of ST3Gal IV and FUT VI gene.

Authors:  Koji Higai; Noriko Miyazaki; Yutaro Azuma; Kojiro Matsumoto
Journal:  FEBS Lett       Date:  2006-10-12       Impact factor: 4.124

5.  Overexpression of ST6GalNAcV, a ganglioside-specific alpha2,6-sialyltransferase, inhibits glioma growth in vivo.

Authors:  Roger A Kroes; Huan He; Mark R Emmett; Carol L Nilsson; Franklin E Leach; I Jonathan Amster; Alan G Marshall; Joseph R Moskal
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-28       Impact factor: 11.205

Review 6.  The glycan code of the endoplasmic reticulum: asparagine-linked carbohydrates as protein maturation and quality-control tags.

Authors:  Daniel N Hebert; Scott C Garman; Maurizio Molinari
Journal:  Trends Cell Biol       Date:  2005-07       Impact factor: 20.808

Review 7.  Cell death and hepatocarcinogenesis: Dysregulation of apoptosis signaling pathways.

Authors:  Jorn Markus Schattenberg; Marcus Schuchmann; Peter Robert Galle
Journal:  J Gastroenterol Hepatol       Date:  2011-01       Impact factor: 4.029

8.  Sialylation of the Fas death receptor by ST6Gal-I provides protection against Fas-mediated apoptosis in colon carcinoma cells.

Authors:  Amanda F Swindall; Susan L Bellis
Journal:  J Biol Chem       Date:  2011-05-05       Impact factor: 5.157

9.  Overexpression of sialyltransferase CMP-sialic acid:Galbeta1,3GalNAc-R alpha6-Sialyltransferase is related to poor patient survival in human colorectal carcinomas.

Authors:  F Schneider; W Kemmner; W Haensch; G Franke; S Gretschel; U Karsten; P M Schlag
Journal:  Cancer Res       Date:  2001-06-01       Impact factor: 12.701

10.  Identification and expression of a sialyltransferase responsible for the synthesis of disialylgalactosylgloboside in normal and malignant kidney cells: downregulation of ST6GalNAc VI in renal cancers.

Authors:  Motohiro Senda; Akihiro Ito; Akiko Tsuchida; Tomoko Hagiwara; Tsuguhiro Kaneda; Yoko Nakamura; Kenji Kasama; Makoto Kiso; Kazuhiro Yoshikawa; Yoko Katagiri; Yoshinari Ono; Manabu Ogiso; Takeshi Urano; Keiko Furukawa; Shinichi Oshima; Koichi Furukawa
Journal:  Biochem J       Date:  2007-03-15       Impact factor: 3.857

View more
  2 in total

1.  Comprehensive quali-quantitative profiling of neutral and sialylated O-glycome by mass spectrometry based on oligosaccharide metabolic engineering and isotopic labeling.

Authors:  Lijing Nan; Jiao Li; Wanjun Jin; Ming Wei; Mengjun Tang; Chengjian Wang; Guiping Gong; Linjuan Huang; Ying Zhang; Zhongfu Wang
Journal:  RSC Adv       Date:  2019-05-20       Impact factor: 4.036

2.  Overexpression of ST3Gal-I promotes migration and invasion of HCCLM3 in vitro and poor prognosis in human hepatocellular carcinoma.

Authors:  Han Wu; Xue-Liang Shi; Hai-Jian Zhang; Qing-Jie Song; Xiao-Bing Yang; Wei-Dong Hu; Guang-Lin Mei; Xi Chen; Qin-Sheng Mao; Zhong Chen
Journal:  Onco Targets Ther       Date:  2016-04-18       Impact factor: 4.147

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.